Latest News about MRK
Recent news which mentions MRK
3 S&P 500 Stocks With 127% to 170% Upside in 2024, According to Select Wall Street Analysts
January 25, 2024
From Motley Fool
From Benzinga
From InvestorPlace
From InvestorPlace
This 1 Bullish Move by Merck Could Drive Growth for Years to Come
January 23, 2024
From Motley Fool
7 Exciting Stocks Poised for Explosive Growth in Key Sectors
January 22, 2024
From InvestorPlace
S&P 500 Shatters Records: The Top-Performing Stocks In January 2024
January 19, 2024
From Benzinga
From Benzinga
Why Is Cancer Focused Adagene Stock Plummeting Today?
January 17, 2024
From Benzinga
The 3 Best Dividend Growth Stocks to Buy in January 2024
January 17, 2024
From InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
January 16, 2024
From Benzinga
Merck's Crown Jewel Cancer Drug Keytruda Scores FDA Approval For Third Indication In Cervical Cancer
January 16, 2024
From Benzinga
7 Healthcare Stocks Taking Medicine to the Next Level
January 14, 2024
From InvestorPlace
Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo And Lilly's Dominance
January 11, 2024
From Benzinga
The 3 Best Blue-Chip Stocks to Buy in January 2024
January 10, 2024
From InvestorPlace
2024 Marks a New Era Of Pharmaceutical Innovation
January 09, 2024
From Benzinga
Why Is $7B Valued Cancer Focused Exelixis Trading Lower Today?
January 08, 2024
From Benzinga
Today Is Cancer-Focused Deals Day: Johnson & Johnson Scoops Up Ambrx Biopharma As Merck Boosts Cancer Portfolio With Harpoon Deal
January 08, 2024
From Benzinga
From Benzinga
Why Is Harpoon Therapeutics (HARP) Stock Up 111% Today?
January 08, 2024
From InvestorPlace
From Benzinga
Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks This Year?
January 08, 2024
From Motley Fool
Strides Toward Lower Drug Costs: Florida Becomes First To Receive Nod To Import Prescription Drugs from Canada
January 05, 2024
From Benzinga
Healthcare Champions Kick Off 2024
January 05, 2024
From Benzinga
Dry January Investing: Trading Pints For Portfolio Growth
January 05, 2024
From Benzinga
P/E Ratio Insights for Merck & Co
January 05, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.